Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

ROsuvastatin Pretreatment in Patients Undergoing Elective PCI to Reduce the Incidence of MyocArdial Periprocedural Necrosis

NCT01007279 is registered in ClinicalTrials.gov with University of Roma La Sapienza as lead sponsor.

NCT NCT01007279
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01007279 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
ROsuvastatin Pretreatment in Patients Undergoing Elective PCI to Reduce the Incidence of MyocArdial Periprocedural Necrosis
Lead sponsor
University of Roma La Sapienza
Phase
Phase 3
Overall status
Completed
Start date
March 31, 2010
Completion date
September 30, 2010
Enrollment
160 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

periprocedural myocardial necrosis